Your browser doesn't support javascript.
loading
COVID-19 Vaccine Booster Hesitancy among Hispanic Adults: A Cross-Sectional Study from the Puerto Rico Community Engagement Alliance against COVID-19 Disparities (PR-CEAL).
Berríos, Hérmilis; López-Cepero, Andrea; Pérez, Cynthia M; Cameron, Stephanie; Pons Calvo, Adriana D; Colón-López, Vivian.
Afiliação
  • Berríos H; Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan 00927, Puerto Rico.
  • López-Cepero A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
  • Pérez CM; Department of Biostatistics and Epidemiology, University of Puerto Rico Medical Sciences Campus, San Juan 00935, Puerto Rico.
  • Cameron S; Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan 00927, Puerto Rico.
  • Pons Calvo AD; Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan 00927, Puerto Rico.
  • Colón-López V; Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan 00927, Puerto Rico.
Vaccines (Basel) ; 11(9)2023 Aug 28.
Article em En | MEDLINE | ID: mdl-37766103
Hispanic/Latino communities have suffered a disproportionate burden of the COVID-19 pandemic. Although Puerto Rico has one of the highest COVID-19 primary series vaccination rates nationwide, this estimate contrasts with the reported booster doses' low uptake. This study aimed to assess health belief correlates of COVID-19 vaccine booster uptake. Using a convenience sampling approach, the Puerto Rico-Community Engagement Alliance (PR-CEAL) conducted a cross-sectional study where 787 participants were recruited using online and in-person strategies between December 2021 and February 2022. Participants were adults 18 years or older, Spanish-speaking, and residents of Puerto Rico. The Health Belief Model was used to evaluate attitudes and beliefs. A total of 784 participants were used in this analysis. Adjusted Poisson regression models were used to estimate prevalence ratios (PR) and 95% confidence intervals (CI) of booster refusal. Overall, 22% of participants refused the vaccine booster or had not gotten it yet. Adjusted models showed that (i) participants who disagreed that getting the booster dose either made them feel less worried about COVID-19 or (ii) felt that the vaccine decreased their chances of getting COVID-19 presented higher booster-refusal prevalence ratios (PR = 4.20, 95% CI: 3.00, 5.90; PR = 3.70, 95% CI: 2.64, 5.18). Moreover, participants that (iii) reported having concerns for booster side effects [PR = 2.47; 95% CI = 1.73, 3.51], (iv) booster efficacy [PR = 2.50; 95% CI = 1.75, 3.58], and (v) booster safety [PR = 2.80; 95% CI = 1.96, 3.99] were significantly more likely to refuse the booster. In conclusion, booster vaccination refusal was associated with lower perceived vaccine benefits and greater barriers among adults in Puerto Rico. These results informed the development of PR-CEAL's targeted community outreach strategies and public health campaigns to increase booster vaccine uptake.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Equity_inequality País/Região como assunto: Puerto rico Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Porto Rico País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Equity_inequality País/Região como assunto: Puerto rico Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Porto Rico País de publicação: Suíça